8-K: Scorpius Holdings Amends Convertible Note and Warrants, Significantly Reduces Conversion and Exercise Prices

Scorpius Holdings amends its senior secured convertible note and common stock purchase warrants with 3i, LP, reducing the conversion and exercise prices to $0.06.

Summary

• Scorpius Holdings, Inc. amended its Senior Secured Convertible Note and Common Stock Purchase Warrant with 3i, LP on May 1, 2025.
• The original principal amount of the note was $12,416,667, issued on December 6, 2024.
• The conversion price of the notes was reduced from $0.25 to $0.06 per share.
• The exercise price of the warrants was also reduced from $0.25 to $0.06 per share.
• If the notes were fully converted at the new price, Scorpius would issue 206,944,450 shares of common stock for the principal amount.
• An additional 34,208,483 shares would be issued if interest and the Make-Whole Amount were also converted.
• The holder can only convert $2,700,000 of the principal until Second Stockholder Approval is obtained.
• The company will seek stockholder approval to increase the authorized number of shares or effect a reverse stock split to allow for complete conversion.

Sentiment

Score: 3

Explanation: The document indicates potential financial strain for Scorpius Holdings, as evidenced by the need to amend the convertible note and warrants with significantly reduced conversion and exercise prices. The potential dilution of existing shareholders is also a concern.

Positives

• The reduced conversion and exercise prices may make it easier for the holder to convert the debt and exercise the warrants.
• The company is actively seeking stockholder approval to allow for complete conversion of the note.

Negatives

• The potential issuance of a large number of shares (206,944,450 plus 34,208,483) upon full conversion could significantly dilute existing shareholders.
• The need for stockholder approval introduces uncertainty and potential delays.

Risks

• Failure to obtain Second Stockholder Approval could limit the holder's ability to convert the full amount of the note.
• The significant increase in the number of outstanding shares could negatively impact the stock price.
• The company's reliance on debt financing and the need for amendments to existing agreements may indicate financial challenges.

Future Outlook

The company will seek stockholder approval to amend its Third Amended and Restated Certificate of Incorporation to allow for complete conversion of the note at the reduced conversion price.

Industry Context

Amendments to convertible notes and warrants are common in situations where companies are facing financial difficulties or need to incentivize investors. The significant reduction in conversion and exercise prices suggests that Scorpius Holdings may be under pressure to improve its financial position.

Comparison to Industry Standards

• It is difficult to compare this specific transaction to industry standards without knowing the specific circumstances of Scorpius Holdings and its industry peers.
• However, similar situations involving distressed companies often result in renegotiated terms that favor the investor in exchange for continued financial support.
• The magnitude of the reduction in conversion and exercise prices is significant and may indicate a high level of financial distress.

Stakeholder Impact

• Shareholders face potential dilution if the note and warrants are fully converted.
• The company's employees and other stakeholders may be affected by the company's financial performance and ability to execute its business plan.
• The investor, 3i, LP, benefits from the reduced conversion and exercise prices, which increase the likelihood of a profitable conversion and exercise.

Next Steps

• Scorpius Holdings will seek Second Stockholder Approval to amend its Third Amended and Restated Certificate of Incorporation.
• The company will need to file the amendment with the Secretary of State of Delaware if the stockholder approval is obtained.

Key Dates

Keywords

convertible note, warrants, amendment, conversion price, exercise price, stockholder approval, dilution, Scorpius Holdings, 3i LP